Fluid mechanics aspects of magnetic drug targeting

References

[1] Alexiou Ch, Arnold W, Hulin P, et al. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic drug targeting. J Magn Magn Mat 2001; 225: 187–193.10.1016/S0304-8853(00)01256-7Search in Google Scholar

[2] Alexiou Ch, Arnold W, Klein RJ, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res 2000; 60: 6641–6648.Search in Google Scholar

[3] Alexiou Ch, Jurgons R, Schmid RJ, et al. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 2003; 11: 139–149.Search in Google Scholar

[4] Alexiou Ch, Tietze R, Schreiber E, et al. Cancer therapy with drug loaded magnetic nanoparticles-magnetic drug targeting. J Magn Magn Mat 2011; 323: 1404–1407.10.1016/j.jmmm.2010.11.059Search in Google Scholar

[5] Arora W, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 2012; 7: 3445–3471.Search in Google Scholar

[6] Banerjee D, Harfouche R, Sengupta Sh. Nanotechnology-mediated targeting of tumor angiogenesis. Vascular Cell 2011; 3: 1–13.10.1186/2045-824X-3-3Search in Google Scholar PubMed PubMed Central

[7] Blanco E, Hsiao A, Mann AP, Landry MG, Meric-Bernstam F, Ferrari M. Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Science 2011; 102: 1247–1252.10.1111/j.1349-7006.2011.01941.xSearch in Google Scholar PubMed

[8] Campbell RB. Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Nanomedicine (Lond.) 2007; 2: 649–652.10.2217/17435889.2.5.649Search in Google Scholar PubMed

[9] Cao Q, Han X, Li L. Enhancement of the efficiency of magnetic targeting for drug delivery: development and evaluation of magnet system. J Magn Magn Mat 2011; 323: 1919–1924.10.1016/j.jmmm.2010.11.058Search in Google Scholar

[10] Chen B, Wu W, Wang X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Curr Cancer Drug Targets 2011; 11: 184–189.10.2174/156800911794328475Search in Google Scholar PubMed

[11] Child HW, Del Pino PA, De La Fuente JM, et al. Working together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D. ACS Nano 2011; 5: 7910–7919.10.1021/nn202163vSearch in Google Scholar PubMed

[12] Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 2006; 67: 55–60.10.1002/ddr.20067Search in Google Scholar

[13] Fan K, Cao C, Pan Y, et al. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nature Nanotechnol 2012; 7: 459–464.10.1038/nnano.2012.90Search in Google Scholar PubMed

[14] Ferrotec: http://www.ferrotec-europe.de/pdf/si/msgw12-de.pdf: Technical data sheet.Search in Google Scholar

[15] Gitter K, Odenbach S. Experimental investigations on a branched tube model in magnetic drug targeting. J Magn Magn Mat 2011; 323: 1413–1416.10.1016/j.jmmm.2010.11.061Search in Google Scholar

[16] Gitter K, Odenbach S. Investigations on a branched tube model in magnetic drug targeting – systematic measurements and simulation. IEEE Transactions on Magnetics 2013; 49: 343–348.10.1109/TMAG.2012.2224324Search in Google Scholar

[17] Gitter K, Odenbach S. Quantitative targeting maps based on experimental investigations for a branched tube model in magnetic drug targeting. J Magn Magn Mat 2011; 323: 3038–3042.10.1016/j.jmmm.2011.06.055Search in Google Scholar

[18] Hayashi K, Nakamura M, Miki H, et al. Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics 2014; 4:834–844.10.7150/thno.9199Search in Google Scholar

[19] Hilger I, Hergt R, Hiergeist R, Schubert H, Kaiser WA. Electromagnetic heating of breast tumors in interventional radiology. In vitro and in vivo studies in human cadavers and mice. Radiology 2001; 218: 570–575.10.1148/radiology.218.2.r01fe19570Search in Google Scholar

[20] Hilger I, Rapp A, Greulich KO, Kaiser WA. Assessment of DNA damage in target tumor cells after thermoablation in mice. Radiology 2005; 237: 500–506.10.1148/radiol.2372041451Search in Google Scholar

[21] Janko C, Dürr S, Munoz LE, et al. Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes. Int J Mol Sci 2013; 14: 7341–7355.10.3390/ijms14047341Search in Google Scholar

[22] Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647.10.1080/02656730500158360Search in Google Scholar

[23] Jordan A, Scholz R, Maier-Hauff K, et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mat 2001; 225: 118–126.10.1016/S0304-8853(00)01239-7Search in Google Scholar

[24] Kayal S, Bandyopadhyay D, Kumar TM, Ramanujan RV. The flow of magnetic nanoparticles in magnetic drug targeting. RSC Adv 2011; 1: 238–246.10.1039/c1ra00023cSearch in Google Scholar

[25] Kettering M, Zorn H, Bremer-Streck S, et al. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol 2009; 54: 5109–5121.10.1088/0031-9155/54/17/003Search in Google Scholar PubMed

[26] Krukemeyer MG, Wagner W, Jakobs M, Krenn V. Tumor regression by means of magnetic drug targeting. Nanomedicine (Lond.) 2009; 4: 857–882.Search in Google Scholar

[27] Kumar A, Jena PK, Behera S, Lockey RF, Mohapatra S, Mohapatra S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 2010; 6: 64–69.10.1016/j.nano.2009.04.002Search in Google Scholar PubMed PubMed Central

[28] Laurent S, Mahmoudi M. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet 2011; 2: 367–390.Search in Google Scholar

[29] Lima R, Joseyphus RJ, Ishikawa T, Imai Y, Yamaguchi T. Micro-flow visualization of magnetic nanoparticles for biomedical applications. In: Dias R, Lima R, Martins AA, Mata TM, editors. Single and two-phase flows on chemical and biomedical engineering. Beijing, China: Bentham e-books 2012: 600–612.10.2174/978160805295011201010600Search in Google Scholar

[30] Lubbe AS, Alexiou Ch, Bergemann C. Clinical applications of magnetic drug targeting. J Surg Res 2001; 95: 200–206.10.1006/jsre.2000.6030Search in Google Scholar PubMed

[31] Luebbe AS, Bergemann C. Magnetically targeted 4’Epidoxorubicin in patients with advanced solid tumors. In: Häfeli U, Schütt W, Teller J, Zborowski M, editors. Scientific and clinical applications of magnetic carriers. Berlin, Heidelberg, Germany: Springer 1997: 456–480.Search in Google Scholar

[32] Luebbe AS, Bergemann C, Huhnt W, et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 1996; 56: 4694–4701.Search in Google Scholar

[33] Lyer S, Tietze R, Jurgons R, et al. Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles – a pilot study. Anticancer Res 2010; 30: 1553–1557.Search in Google Scholar

[34] Namdeo M, Saxena S, Tankhiwale R, Bajpai M, Mohan YM, Bajpai SK. Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechno 2008; 8: 3247–3271.10.1166/jnn.2008.399Search in Google Scholar PubMed

[35] Nowak J, Odenbach S. magnetoviscous effect in a biocompatible ferrofluid. IEEE Transactions on Magnetics 2013; 49: 208–212.10.1109/TMAG.2012.2224646Search in Google Scholar

[36] Nowak J, Nowak C, Odenbach S. Consequences of sheep blood used as diluting agent for the magnetoviscous effect in biocompatible ferrofluids. Appl Rheol 2015; 25: 53250.Search in Google Scholar

[37] Nowak J, Wolf D, Odenbach S. A rheological and microscopical characterization of biocompatible ferrofluids. J Magn Magn Mat 2014; 354: 98–104.10.1016/j.jmmm.2013.10.050Search in Google Scholar

[38] Odenbach S. Magnetoviscous effects in ferrofluids. Springer Lecture Notes in Physics m71 2002; Springer, Berlin, Heidelberg.10.1007/3-540-45646-5Search in Google Scholar

[39] Odenbach S, Raj K. The influence of particle agglomerates on the magnetoviscous effect in ferrofluids. Magnetohydrodynamics 2000; 36: 4.10.1023/A:1010496907449Search in Google Scholar

[40] Owen J, Pankhurst Q, Stride E. Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination. Int J Hyperthermia 2012; 28: 362–373.10.3109/02656736.2012.668639Search in Google Scholar PubMed

[41] Peng M, Li H, Luo Z, et al. Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. Nanoscale 2015; 7: 11155–11162.10.1039/C5NR01382HSearch in Google Scholar PubMed

[42] Pop LM, Odenbach S. Capillary viscosimetry on ferrofluids. J Phys Condens Matter 2008; 20: 204139.10.1088/0953-8984/20/20/204139Search in Google Scholar PubMed

[43] Rahn H, Odenbach S. X-ray micro-tomography as tool for the investigation of the biodistribution of magnetic nanoparticles. Nanomedicine 2009; 4: 981–990.10.2217/nnm.09.82Search in Google Scholar PubMed

[44] Rahn H, Alexiou Ch, Trahms L, Odenbach S. 3-Dimensional quantitative detection of nanoparticle content in biological tissue samples after local cancer treatment. J Magn Magn Mat 2014; 360: 92–97.10.1016/j.jmmm.2014.02.021Search in Google Scholar

[45] Rahn H, Gomez-Morilla I, Jurgons R, Alexiou Ch, Eberbeck D, Odenbach S. Tomographic examination of magnetic nanoparticles used as drug carriers. J Magn Magn Mat 2009; 312: 1517–1520.10.1016/j.jmmm.2009.02.078Search in Google Scholar

[46] Richter H, Kettering M, Wiekhorst F, Steinhoff U, Hilger I, Trahms L. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys Med Biol 2010; 55: 623–633.10.1088/0031-9155/55/3/005Search in Google Scholar PubMed

[47] Seliger C, Jurgons R, Wiekhorst F, et al. In vitro investigation of the behaviour of magnetic particles by a circulating artery model. J Magn Magn Mat 2007; 311: 358–362.10.1016/j.jmmm.2006.10.1205Search in Google Scholar

[48] Sensenig R, Sapir Y, MacDonald C, Cohen S, Polyak B. Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine (Lond.) 2012; 7: 1425–1442.Search in Google Scholar

[49] Silva A, Silva-Freitas É, Carvalho J, et al. Magnetic Particles in Biotechnology: from drug targeting to tissue engineering. In: Petre M, editor. Advances in applied biotechnology. Rijeka, Croatia: INTECH 2012: 237–256.10.5772/30624Search in Google Scholar

[50] Theumer A, Gräfe Ch, Bähring F, Bergemann Ch, Hochhaus A, Clement JH. Superparamagnetic iron oxide nanoparticles exert different cytotoxic effects on cells grown in monolayer cell culture versus as multicellular spheroids. J Magn Magn Mat 2015; 380: 27–33.10.1016/j.jmmm.2014.10.039Search in Google Scholar

[51] Thurm S, Odenbach S. Particle size distribution as key parameter for the flow behaviour of ferrofluids. Physics of Fluids 2003; 15: 1658.10.1063/1.1572873Search in Google Scholar

[52] Tietze R, Lyer S, Dürr S, et al. Efficient drug-delivery using magnetic nanoparticles – biodistribution and therapeutic effects in tumour bearing rabbits. Nanomedicine: Nanotechnology, Biology and Medicine 2013; 9: 961–971.10.1016/j.nano.2013.05.001Search in Google Scholar PubMed

[53] Tietze R, Rahn H, Lyer S, et al. Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology. Histochem Cell Biol 2011; 135: 153–158.10.1007/s00418-011-0780-8Search in Google Scholar PubMed

[54] Torchilin VP. Nanocarriers for the delivery of drugs, genes, and diagnostics. In: Alexiou C, editor. Nanomedicine – basic and clinical applications in diagnostics and therapy. Basel, Switzerland: Karger 2011: 15–34.10.1159/000328881Search in Google Scholar

[55] Weaver JB, Zhang X, Kuehlert E, et al. Quantification of magnetic nanoparticles with low frequency magnetic fields: compensating for relaxation effects. Nanotechnol 2013; 24: 325502.10.1088/0957-4484/24/32/325502Search in Google Scholar PubMed PubMed Central

[56] Wiekhorst F, Seliger C, Jurgons R, et al. Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting. J Nanosci Nanotechnol 2006; 6: 3222–3225.10.1166/jnn.2006.477Search in Google Scholar PubMed

[57] Yu MK, Park J, Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012; 2: 3–44.10.7150/thno.3463Search in Google Scholar PubMed PubMed Central

[58] Zheng J, Wang J, Tang T, Li G, Cheng H, Zou Sh. Experimental study on magnetic drug targeting in treating cholangiocarcinoma based on internal magnetic fields. Chin Ger J Clin Oncol 2006; 5: 336–338.10.1007/s10330-006-0492-zSearch in Google Scholar